Is 'chemo-fog'/'chemo-brain' caused by cancer chemotherapy?

Journal of Clinical Pharmacy and Therapeutics

Volumn 31, Issue 2, 2006, Pages 129-138

  Raffa, R B ^a   Duong, P V ^a   Finney, J ^a   Garber, D A ^a   Lam, L M ^a   Mathew, S S ^a   Patel, N N ^a   Plaskett, K C ^a   Shah, M ^a   Jen Weng, H F ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTOKINE; DOCETAXEL; EPIRUBICIN; ESTROGEN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; METHYLPHENIDATE; MODAFINIL; PACLITAXEL; RECOMBINANT ERYTHROPOIETIN; TAMOXIFEN; THIOTEPA; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN FUNCTION; BRAIN METASTASIS; BRAIN RADIATION; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CHILD; CHILDHOOD LEUKEMIA; CHRONIC DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DRUG MEGADOSE; ESTROGEN DEFICIENCY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAZE TEST; MENOPAUSAL SYNDROME; MOUSE; NEUROPSYCHOLOGICAL TEST; NONHUMAN; NOTE; TREATMENT OUTCOME;

AGED; ANIMALS; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; HUMANS; MIDDLE AGED; NEOPLASMS; NEUROPSYCHOLOGICAL TESTS; RANDOMIZED CONTROLLED TRIALS;

EID: 33645465212     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2006.00726.x     Document Type: Note

References (55)

1. Olin JJ 2001 Cognitive function after systemic therapy for breast cancer Oncology 15 613 618
2. Anderson-Hanley C Sherman ML Riggs R Agocha B Compas B 2003 Neuropsychological effect of treatments for adults with cancer: A meta-analysis and review of the literature Journal of the International Neuropsychological Society 9 967 982
3. Phillips KA Bernhard J 2003 Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions Journal of the National Cancer Institute 95 190 197
4. Tannock IF Tim AA Ganz PA van Dam FS 2004 Cognitive impairment associated with chemotherapy for cancer: report of a workshop Journal of Clinical Oncology 22 2233 2239
5. Wieneke MH Dienst ER 1995 Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer Psychooncology 4 61 66
6. Van Dam FS Schagen SB Muller MJ Boogerd W Wall E Fortuyn M Rodenhuis S 1998 Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy Journal of the National Cancer Institute 90 210 218
7. Schagen S van Dam F Muller M Boogerd W Lindeboom J Bruning P 1999 Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma Cancer 85 640 650
8. Schagen SB Muller MJ Boogerd W Rosenbrand RM Rhijn D Rodenhuis S van Dam FS 2002 Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients Annals of Oncology 13 1387 1397
9. Brezden C Phillips K Abdolell M Bunston T Tannock I 2000 Cognitive function in breast cancer patients receiving adjuvant chemotherapy Journal of Clinical Oncology 18 2695 2701
10. Ahles TA Saykin AJ Furstenberg CT et al. 2002 Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma Journal of Clinical Oncology 20 485 493
11. O'Shaughnessy JA 2002 Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy Clinical Breast Cancer 3 Suppl. 3 S116 S120
12. Tchen N Juffs HG Downie FP et al. 2003 Cognitive changes, fatigue and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer: a prospective matched cohort study Journal of Clinical Oncology 21 4175 4183
13. Wefel JS Lenzi R Theriault RL Davis RN Meyers CA 2004 The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial Cancer 100 2292 2299
14. Meyers C 2000 Neurocognitive dysfunction in cancer patients Oncology 14 75 81
15. Silberfarb PM Philibert D Levine PM 1980 Psychosocial aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients American Journal of Psychiatry 137 597 601
16. Schagen SB Hamburger HL Muller MJ et al. 2001 Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function Journal of Neurooncology 51 159 165
17. Kingma A van Dommelen RI Mooyaart EL Wilmink JT Deelman BG Kamps WA 2001 Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only Journal of Pediatrics 139 413 420
18. Kibiger G Kirsh KL Wall JR Passik SD 2003 My mind is as clear as it used to be: a pilot study illustrating the difficulties of employing a single-item subjective screen to detect cognitive impairment in outpatients with cancer Journal of Pain and Symptom Management 26 705 715
19. Appleton RE Farrell K Zaide J Rogers P 1990 Decline in head growth and cognitive impairment in survivors of acute lymphoblastic leukemia Archives of Disease in Childhood 65 530 534
20. Van Oosterhout AG Ganzevles PG Wilmink JT De Geus BW Van Vonderen RG Twijnstra A 1996 Sequelae in long-term survivors of small cell lung cancer International Journal of Radiation Oncology and Biological Physics 34 1037 1044
21. Ahles TA 2004 Do systemic cancer treatments affect cognitive function? Lancet Oncology 5 270 271
22. Riva D Giorgi C Nichelli F et al. 2002 Intrathecal methotrexate affects cognitive function in children with medulloblastoma Neurology 59 48 53
23. Brown RT Madan-Swain A Walco GA et al. 1998 Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis Journal of Pediatric Psychiatry 23 333 340
24. Shilling V Jenkins V Fallowfield L Howell T 2003 The effects of hormone therapy on cognition in breast cancer Journal of Steroid Biochemistry and Molecular Biology 86 405 412
25. Cimprich B Ronis DL 2001 Attention and symptom distress in women with and without breast cancer Nursing Research 50 86 94
26. Wefel S Lenzi R Theriault R Buzdar A Cruickshank S Meyers C 2004 'Chemobrain' in breast carcinoma? A prologue Cancer 101 466 475
27. Hannay HJ Levin HS 1985 Selective reminding test: an examination of the equivalence of four forms Journal of Clinical and Experimental Neuropsychology 7 251 263
28. Almeida OP Flicker L 2001 The mind of a failing heart: a systematic review of the association between congestive heart failure and cognitive functioning Internal Medicine Journal 31 290 295
29. Allena KV Frier BM Strachan MWJ 2004 The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations European Journal of Pharmacology 490 169 175
30. Liesker JJ Postma DS Beukema RJ et al. 2004 Cognitive performance in patients with COPD Respiratory Medicine 98 351 356
31. Antonelli Incalzi R Marra C Giordano A et al. 2003 Cognitive impairment in chronic obstructive pulmonary disease. A neuropsychological and SPECT study Journal of Neurology 250 325 332
32. Wilson RS Mendes de Leon CF Bennett DA Bienias JL Evans DA 2004 Depressive symptoms and cognitive decline in a community population of older persons Journal of Neurology and Neurosurgical Psychiatry 75 12126 12129
33. Holland J 2001 New treatment modalities in radiation therapy Journal of Intravenous Nursing 24 95 101
34. Noad R Narayanan KR Howlett T Lincoln NB Page RC 2004 Evaluation of effects of radiotherapy for pituitary tumors on cognitive function and quality of life Clinical Oncology Royal College Radiologists 16 233 237
35. Keime-Guibert F Napolitano M Delattre J 1998 Neurological complications of radiotherapy and chemotherapy Journal of Neurology 245 695 708
36. Bonadonna G Brusamolino E Valagussa P 1976 Combination chemotherapy as an adjuvant treatment in operable breast cancer New England Journal of Medicine 294 405 410
37. Bonadonna G Valagussa P Moliterni A Zambetti M Brambilla C 1995 Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years follow-up New England Journal of Medicine 332 901 906
38. Harris J Morrow M Norton L 1997 Cancer of the breast In DeVita VT Hellman S Rosenberg SA eds Cancer: principles & practice of oncology, vol. 2, 5th edn
39. Kemper E Boogerd W Thuis I Beijnen JH van Tellingen O 2004 Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours? Cancer Treatment Reviews 30 415 423
40. Neuwelt EA Barnett P Barranger J McCormick C Pagel M Frenkel E 1983 Inability of dimethyl sulfoxide and 5-fluorouracil to open the blood-brain barrier Neurosurgery 12 29 34
41. MacDonell LA Potter PE Leslie RA 1978 Localized changes in blood-brain barrier permeability following the administration of antineoplastic drugs Cancer Research 38 2930 2934
42. Fenner MH Possinger K 2002 Chemotherapy for breast cancer brain metastases Onkologie 25 474 479
43. Neuwelt EA Barnett PA Frenkel EP 1984 Chemotherapeutic agent permeability to normal brain and delivery to avian sarcoma virus-induced brain tumors in the rodent: observations on problems of drug delivery Neurosurgery 14 154 160
44. Fliessbach K Urbach H Helmstaedter C et al. 2003 Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma Archives of Neurology 60 563 568
45. Rock E DeMichele A 2003 Nutritional approaches to late toxicities of adjuvant chemotherapy in breast cancer survivors Journal of Nutrition 133 3785S 3793S
46. Birge SJ 2003 The use of estrogen in older women Clinical Geriatric Medicine 19 617 627
47. Cunningham RS 2003 Anemia in the oncology patient: cognitive function and cancer Cancer Nursing 26 39S 41S
48. Maier SF Watkins LR 2003 Immune-to-central nervous system communication and its role in modulating pain and cognition: implications for cancer and cancer treatment Brain, Behavior and Immunity 17 S125 S131
49. Pusztai L Mendoza TR Reuben JM et al. 2004 Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy Cytokine 25 94 102
50. Wilson CJ Finch CE Cohen HJ 2002 Cytokines and cognition - the case for a head-to-toe inflammatory paradigm Journal of the Geriatric Society 50 2041 2056
51. Sallah S Wan JY Nguyen NP 2002 Venous thrombosis in patients with solid tumors: determination of frequency and characteristics Thrombosis Haemostasis 87 575 579
52. Caine GJ Stonelake PS Rea D Lip GY 2003 Coagulopathic complications in breast cancer Cancer 98 1578 1586
53. Love S. 2006 Chemobrain/cognitive dysfunction. The website for women (accessed on 23 March 2006)
54. Foreman J. 2003 ''Chemo Brain" leaves patients at a loss. Health sense columns
55. Madhyastha S Somayaji SN Rao MS Nalini K Bairy KL 2002 Hippocampal brain amines in methotrexate-induced learning and memory deficit Canadian Journal of Physiology and Pharmacology 80 1076 1084